Obsidian Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Obsidian Therapeutics, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-29.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 63% of Healthcare companies in United States.
Cash Cushion Ratio
+9%Cash, after subtracting all debt, equals 9% of its market value (net cash).
Lower than 51% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Obsidian Therapeutics, Inc. made a loss over the last year. Obsidian Therapeutics, Inc. owes $4.94 for every $1 it owns. Obsidian Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossObsidian Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-3.13Obsidian Therapeutics, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$864 MThe total market value of all of Obsidian Therapeutics, Inc.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeObsidian Therapeutics, Inc.'s net worth is negative ($276 M below zero, balance sheet 31 Mar 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
4.94×Obsidian Therapeutics, Inc. owes $4.94 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Dividend yield
NoneObsidian Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossObsidian Therapeutics, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashObsidian Therapeutics, Inc. held $76 M more cash than debt (net cash) at Dec 2025.
Questions
How much does Obsidian Therapeutics, Inc. owe compared with what it owns?
Obsidian Therapeutics, Inc. owes $4.94 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Does Obsidian Therapeutics, Inc. pay a dividend?
No. Obsidian Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.